SYH2072

Primary objective: To evaluate the safety and tolerability of SYH2072 tablets after single and multiple oral administration in healthy Chinese participants; Secondary objectives: To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of SYH2072 tablets after single and multiple oral administration in healthy Chinese participants; to evaluate the effect of a single oral administration of SYH2072 tablets on the QT/QTc interval in healthy Chinese participants; and to evaluate the effect of food on the PK characteristics of SYH2072 tablets after a single oral administration.